2021
DOI: 10.1007/s10753-021-01479-y
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory and Hepatoprotective Effects of Quercetin in an Experimental Model of Rheumatoid Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 51 publications
0
18
0
Order By: Relevance
“…Furthermore, clinical trials of RA patients with different disease activity, larger sample size, gender difference, NF-κB 21 CIA model 150 mg•kg −1 •0.5 mL −1 three times a week orally administrated for 17 or 28 days; 23 0, 50, 100mg/kg/d orally administrated for 5 weeks; 24 150mg/kg daily orally administrated for 14 days 22 or 21 days; 25 30mg/kg daily orally administrated for 49 days 26 Mitigated paw edema, inflammatory cells infiltration, synovium hyperplasia, cartilage and bone erosion, decreased TNF-α, IL-1β, IL-6, PGE2, and NLRP3 inflammasome (NLRP3, Caspase-1 and IL-1β) [22][23][24][25][26] SIRT1/PGC-1α/NRF1/ TFAM and HMGB1/TLR4/ p38/ERK1/2/NF-κB p65 24 AA model 150 mg/rat (30 mg every 2 days, orally administrated for 10 days) or 25, 50 mg/rat (5 or 10 mg every 2 days, intra-cutaneous injection following the appearance of first arthritic symptoms); 27 Reduced arthritis scores, paw thickness and inflammatory infiltration, increase paw thermal latency. [27][28][29][30][31][32] Increased IL-4 and IL-10, decreased TNF-α, NO, IFN-γ, IL-6, IL-1β, MCP-1, MPO, [27][28][29][30]32,33 decreased 12/15-LOX in liver and lung. 33 Decreased ADA enzyme activity and gene expression in sera and joints 28 GSK-3β, NF-κB and ERK 30,32,33 Human RAFLS 50 nmol/L; 37 0, 20, 100, 200μM 38 Decreased IL-1β stimulated COX-2 and PGE2, 38 decreased TNF-αinduced IL-1β, IL-6, IL-8 and MCP-1 36,37 MAPKs (ERK, p-38, JNK) 38 and NF-κB, 36,38 lncRNA XIST/miR-485/PSMB8 axis 37 Inhibition of oxidative stress Zymosaninduced arthritis mice 0, 10, 30, 100 mg/kg s.c. 30 min before z...…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Furthermore, clinical trials of RA patients with different disease activity, larger sample size, gender difference, NF-κB 21 CIA model 150 mg•kg −1 •0.5 mL −1 three times a week orally administrated for 17 or 28 days; 23 0, 50, 100mg/kg/d orally administrated for 5 weeks; 24 150mg/kg daily orally administrated for 14 days 22 or 21 days; 25 30mg/kg daily orally administrated for 49 days 26 Mitigated paw edema, inflammatory cells infiltration, synovium hyperplasia, cartilage and bone erosion, decreased TNF-α, IL-1β, IL-6, PGE2, and NLRP3 inflammasome (NLRP3, Caspase-1 and IL-1β) [22][23][24][25][26] SIRT1/PGC-1α/NRF1/ TFAM and HMGB1/TLR4/ p38/ERK1/2/NF-κB p65 24 AA model 150 mg/rat (30 mg every 2 days, orally administrated for 10 days) or 25, 50 mg/rat (5 or 10 mg every 2 days, intra-cutaneous injection following the appearance of first arthritic symptoms); 27 Reduced arthritis scores, paw thickness and inflammatory infiltration, increase paw thermal latency. [27][28][29][30][31][32] Increased IL-4 and IL-10, decreased TNF-α, NO, IFN-γ, IL-6, IL-1β, MCP-1, MPO, [27][28][29][30]32,33 decreased 12/15-LOX in liver and lung. 33 Decreased ADA enzyme activity and gene expression in sera and joints 28 GSK-3β, NF-κB and ERK 30,32,33 Human RAFLS 50 nmol/L; 37 0, 20, 100, 200μM 38 Decreased IL-1β stimulated COX-2 and PGE2, 38 decreased TNF-αinduced IL-1β, IL-6, IL-8 and MCP-1 36,37 MAPKs (ERK, p-38, JNK) 38 and NF-κB, 36,38 lncRNA XIST/miR-485/PSMB8 axis 37 Inhibition of oxidative stress Zymosaninduced arthritis mice 0, 10, 30, 100 mg/kg s.c. 30 min before z...…”
Section: Discussionmentioning
confidence: 99%
“… 42 Another study indicated that the levels of ALT and AST of methotrexate (MTX) treatment group were higher than control group, while QUE co-administered with MTX could reverse the hepatotoxicity. 31 …”
Section: Pharmacological Mechanism Of Que In Pre-clinical Studies ( ...mentioning
confidence: 99%
See 2 more Smart Citations
“…235,237 There is no experimental and clinical evidence revealing the antiarthritic effect of the crude extract of the plant; however, some of the bioactive compounds found in the plant have antiarthritic activities. For instance, the antiarthritic effects of quercetin, [177][178][179] caffeic acid, 191 and chlorogenic acid 200,238 have been reported.…”
Section: Complementary and Alternative Medicine: Potential Elixirs Fo...mentioning
confidence: 99%